Cited by 850Multiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersOcular Diseases and Behçet’s Syndrome

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Open access

Sato, Douglas Kazutoshi, Callegaro, Dagoberto, Lana-Peixoto, Marco Aurelio, Waters, Patrick J., Jorge, Frederico M. de Haidar, Takahashi, Toshiyuki, Nakashima, Ichiro, Apostolos-Pereira, Samira Luisa, Talim, Natalia, Simm, Renata Faria, Lino, Angelina Maria Martins, Misu, Tatsuro, Leite, Maria Isabel, Aoki, Masashi, Fujihara, Kazuo·2014·Neurology

DOI 10.1212/wnl.0000000000000101PMC PMC3937859

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein (MOG) antibodies, aquaporin-4 (AQP4) antibodies, or seronegativity for both antibodies. METHODS: Sera from patients diagnosed with NMOSD in 1 of 3 centers (2 sites in Brazil and 1 site in Japan) were tested for MOG and AQP4 antibodies using cell-based assays with live transfected cells. RESULTS: Among the 215 patients with NMOSD, 7.4% (16/215) were positive for MOG antibodies and 64.7% (139/215) were positive for AQP4 antibodies. No patients were positive for both antibodies. Patients with MOG antibodies represented 21.1% (16/76) of the patients negative for AQP4 antibodies. Compared with patients with AQP4 antibodies or patients who were seronegative, patients with MOG antibodies were more frequently male, had a more restricted phenotype (optic nerve more than spinal cord), more frequently had bilateral simultaneous optic neuritis, more often had a single attack, had spinal cord lesions distributed in the lower portion of the spinal cord, and usually demonstrated better functional recovery after an attack. CONCLUSIONS: Patients with NMOSD with MOG antibodies have distinct clinical features, fewer attacks, and better recovery than patients with AQP4 antibodies or patients seronegative for both antibodies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000000101

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. E., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,819
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study
Kitley, J., Waters, P., Woodhall, M., Leite, M. I., Murchison, A., George, J., Küker, W., Chandratre, S., Vincent, A., & Palace, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5857 · Cited by 597
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
Waters, P. J., McKeon, A., Leite, M. I., Rajasekharan, S., Lennon, V. A., Villalobos, A., Palace, J., Mandrekar, J. N., Vincent, A., Bar-Or, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318248dec1 · Cited by 526
Self-citation
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Mader, S., Gredler, V., Schanda, K., Rostasy, K. M., Dujmović, I., Pfaller, K., Lutterotti, A., Jarius, S., Pauli, F. D., Kuenz, B., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-184 · Cited by 449
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
O’Connor, K. C., McLaughlin, K. A., Jager, P. L. D., Chitnis, T., Bettelli, E., Xu, C., Robinson, W. H., Cherry, S. V., Bar‐Or, A., Banwell, B., et al. (2007) · Nature Medicine · doi:10.1038/nm1488 · Cited by 419
The spectrum of MOG autoantibody-associated demyelinating diseases
Reindl, M., Pauli, F. D., Rostasy, K. M., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 376

Show all 21 references

Sorted by citations

Items 501–600 of 848

Misdiagnosis in multiple sclerosis in a Brazilian reference center: Clinical, radiological, laboratory profile and failures in the diagnostic process—Cohort study
Tieppo, E. M. D. S., Silva, G. D., da Silva, T. F. F., de Araujo, R. S., de Oliveira, M. B., Spricigo, M. G. P., Pimentel, G. A., Campana, I. G., Castrillo, B. B., Mendes, N. T., et al. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585231199323 · Cited by 10
Clinical and Imaging Findings in Children with Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD): From Presentation to Relapse
George, E., Russ, J. B., Valdrighi, A., Early, H. M., Mamlouk, M. D., Glenn, O. A., Francisco, C., Waubant, E. L., Lindan, C. E., & Li, Y. (2024) · American Journal of Neuroradiology · doi:10.3174/ajnr.a8089 · Cited by 9
Clinical characteristics and factors associated with recurrence and long-term prognosis in patients with MOGAD
Sun, W., Xie, Y., Han, A., Zhou, X., Zhang, S., Xie, Y., & Xie, N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1535571 · Cited by 9
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy
Miyazaki, T., Nakajima, H., Motomura, M., Tanaka, K., Maeda, Y., Shiraishi, H., & Tsujino, A. (2016) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-000756 · Cited by 9
Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder
Seze, J. D. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000650 · Cited by 9
Comparison of Visual Evoked Potentials in Patients Affected by Optic Neuritis From Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder
Filgueiras, T. G., Oyamada, M. K., Hokazono, K., Cunha, L. P., Apóstolos‐Pereira, S. L., Callegaro, D., & Monteiro, M. L. R. (2021) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001285 · Cited by 9
Usefulness of two-dimensional measurements for the evaluation of brain volume and disability in multiple sclerosis
Ajitomi, S., Fujimori, J., & Nakashima, I. (2022) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/20552173211070749 · Cited by 9
Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents
Paolilo, R. B., da Paz, J. A., Apóstolos‐Pereira, S. L., Rimkus, C. D. M., Callegaro, D., & Sato, D. K. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1761432 · Cited by 9
Evaluation and Treatment of Autoimmune Neurologic Disorders in the Pediatric Intensive Care Unit
Benson, L. A., Olson, H. E., & Gorman, M. (2014) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2014.12.008 · Cited by 9
Anti‐myelin oligodendrocyte glycoprotein antibody in demyelinating diseases
Nakashima, I. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12262 · Cited by 9
The Prevalence of Anti-Aquaporin 4 Antibody in Patients with Idiopathic Inflammatory Demyelinating Diseases Presented to a Tertiary Hospital in Malaysia: Presentation and Prognosis
Abdullah, S., Wong, W. F., & Tan, C. T. (2017) · Multiple Sclerosis International · doi:10.1155/2017/1359761 · Cited by 9
Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal Detachment
Kon, T., Hikichi, H., Ueno, T., Suzuki, C., Nunomura, J., Kaneko, K., Takahashi, T., Nakashima, I., & Tomiyama, M. (2018) · Internal Medicine · doi:10.2169/internalmedicine.9840-17 · Cited by 9
The clinical value of the albumin quotient in patients with neuromyelitis optica spectrum disorder
Chen, B., Qin, C., Tao, R., Dong, Y., Ma, X., Chen, M., Wu, L., Bu, B., & Tian, D. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101880 · Cited by 9
Diagnosis and Management of Central Nervous System Demyelinating Disorders
Touma, L., & Muccilli, A. D. (2021) · Neurologic Clinics · doi:10.1016/j.ncl.2021.08.008 · Cited by 9
Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis: an updat
Messias, K., Marques, V. D., & Messias, A. M. V. (2023) · Arquivos Brasileiros de Oftalmologia · doi:10.5935/0004-2749.20230012 · Cited by 11
Neuromyelitis optica and myasthenia gravis in a young Nigerian girl
Balarabe, S. A., Adamu, M. D., Watila, M. M., & Jiya, N. (2015) · BMJ Case Reports · doi:10.1136/bcr-2014-207362 · Cited by 9
Practice Current: How do you treat neuromyelitis optica?
Ganesh, A. (2017) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000352 · Cited by 9
Tumefactive Demyelinating Lesions in Children: A Rare Case of Conus Medullaris Involvement and Systematic Review of the Literature
Pérez, C. A., Patnaik, A., Oommen, S., Redko, A., & Mathis, S. B. (2020) · Journal of Child Neurology · doi:10.1177/0883073820924147 · Cited by 9
Long-term outcome of a group of Japanese children with myelin-oligodendrocyte glycoprotein encephalomyelitis without preventive immunosuppressive therapy
Hino‐Fukuyo, N., Haginoya, K., Takahashi, T., Nakashima, I., Fujihara, K., Takai, Y., Akasaka, M., & Kure, S. (2019) · Brain and Development · doi:10.1016/j.braindev.2019.06.004 · Cited by 9
Immunohistochemistry
Höftberger, R., Mader, S., & Reindl, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-01225-4_12 · Cited by 10
Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice
Aktaş, O. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309057 · Cited by 9
MOG-IgG serological status matters in paediatric ADEM
Misu, T., Sato, D. K., Nakashima, I., & Fujihara, K. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308723 · Cited by 9
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and Human Immunodeficiency virus infection: dilemmas in diagnosis and management: a case series
Gadama, Y., Preez, M. D., Carr, J. A., Theron, S., Albertyn, C., Ssebambulidde, K., Saylor, D. R., Brey, N., & Henning, F. (2023) · Journal of Medical Case Reports · doi:10.1186/s13256-023-04191-7 · Cited by 8
Review of atypical optic neuritis
Zoric, L. D., & Čolak, E. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07895-w · Cited by 8
Recommendations on neurologic, cognitive, and psychiatric manifestations in patients with Sjögren’s disease by the Brazilian Society of Rheumatology
de Oliveira, F. R., Appenzeller, S., Pasoto, S. G., Fernandes, M. L. M. S., Lopes, M. L. L., Fialho, S. C. D. M. S., Pinheiro, A. C., dos Santos, L. C., Valim, V., Serrano, É. V., et al. (2025) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-025-00438-7 · Cited by 8
Latin American RAND/UCLA modified Delphi consensus recommendations for management and treatment of adult MOGAD patients in clinical practice
Contentti, E. C., Correale, J. D., Rojas, J. I., Alonso, R. N., Becker, J., Zamalloa, C. C., Díaz, E. P. C., Flores-Rivera, J. D. J., Arango, J. A. J., Lana–Peixoto, M. A., et al. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106460 · Cited by 10
Controversies in the management of neuromyelitis optica spectrum disorder
Bruscolini, A., Cava, M. L., Mallone, F., Marcelli, M., Ralli, M., Sagnelli, P., Greco, A., & Lambìase, A. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1648210 · Cited by 8
Clinical characteristics and prognosis of optic neuritis in Taiwan - a hospital-based cohort study
Lin, C., Chen, W.-T., Lin, Y., Hung, K., & Chen, T. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104739 · Cited by 8
Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan
Saida, T., Yokoyama, K., Sato, R., Makioka, H., Iizuka, Y., Hase, M., Yan, L., & Torii, S. (2017) · Neurology and Therapy · doi:10.1007/s40120-017-0084-6 · Cited by 8
Differences in Clinical Features of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in White and Asian Race
Padungkiatsagul, T., Chen, J. J.-W., Jindahra, P., Akaishi, T., Takahashi, T., Nakashima, I., Takeshita, T., & Moss, H. E. (2020) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2020.07.008 · Cited by 8
Asymptomatic MRI lesions in pediatric-onset AQP4-IgG positive NMOSD
Paolilo, R. B., Rimkus, C. D. M., da Paz, J. A., Apóstolos‐Pereira, S. L., Callegaro, D., & Sato, D. K. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104215 · Cited by 8
How to improve the sensitivity and specificity of cell-based assays in detecting autoantibodies in neuroimmune diseases
Gao, F., Zhang, Y., Lv, J., Wang, S., He, X., Liu, P., & Cui, W. (2023) · Annals of Translational Medicine · doi:10.21037/atm-21-3072 · Cited by 8
Clinical manifestations of neuromyelitis optica in male and female patients
Yin, J., Long, Y., Shan, F., Fan, Y., Wu, L., Zhong, R., Gao, C., Chen, X., Gao, Q., & Yang, N. (2015) · Neurological Research · doi:10.1179/1743132815y.0000000081 · Cited by 8
Should Plasma Exchange Be Offered to Patients With Multiple Sclerosis–Associated Optic Neuritis?
Pula, J. H., & Glisson, C. C. (2015) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000197 · Cited by 8
MOG-antibody-associated disease is different from MS and NMO and should be considered as a distinct disease entity – No
Cobo‐Calvo, Á., & Marignier, R. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519863135 · Cited by 8
Pediatric Demyelination
Narula, S., & Banwell, B. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000326 · Cited by 9
Neuromyelitis Optica: Review and Utility of Testing Aquaporin-4 Antibody in Typical Optic Neuritis
Seay, M. D., & Rucker, J. C. (2018) · Asia-Pacific Journal of Ophthalmology · doi:10.22608/apo.2018170 · Cited by 9
Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype
Navarro-Cantó, L., Carratalà‐Boscà, S., Vicente, C. A., Gil‐Perotín, S., Miralles, F. C. P., Castillo-Villalba, J., Cubas-Núñez, L., & Estruch, B. C. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01157 · Cited by 8
MRI features of myelin oligodendrocyte glycoprotein antibody disease: a descriptive study—how it differs from neuromyelitis optica spectrum disorders and multiple sclerosis
Mishael, J. T., Sandeep, S., George, A., Philip, B., & Deepalam, S. R. (2023) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-023-01066-1 · Cited by 7
CD4-Positive T-Cell Responses to MOG Peptides in MOG Antibody-Associated Disease
Ono, H., Misu, T., Namatame, C., Matsumoto, Y., Takai, Y., Nishiyama, S., Kuroda, H., Takahashi, T., Nakashima, I., Fujihara, K., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083606 · Cited by 7
The first Japanese report on neuromyelitis optica rediscovered: acute bilateral blindness, tetraparesis and respiratory insufficiency in a 35-year-old man (1891)
Jarius, S., Wuthenow, A.-B., & Wildemann, B. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.09.005 · Cited by 7
Decipher potential biomarkers of diagnosis and disease activity for NMOSD with AQP4 using LC-MS/MS and Simoa
Wang, J., Wang, J., Xie, W., Liu, J., Feng, J., Wei, W., Li, M., Wu, L., Wang, C., & Li, R. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109761 · Cited by 7
Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis Presenting as Idiopathic Orbital Inflammatory Syndrome
Wagley, S., Wang, Y., McClelland, C. M., Chen, J. J.-W., & Lee, M. S. (2020) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000918 · Cited by 7
The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
Xu, J., Liu, L., Xiong, J., Zhang, L., Huang, P. F., Tang, L., Xiao, Y., Li, X., Li, J., Luo, Y., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.679430 · Cited by 7
Isolated Double-Positive Optic Neuritis: A Case of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody Seropositivity
Mason, M., Marotta, D. A., & Kesserwani, H. N. (2021) · Cureus · doi:10.7759/cureus.15389 · Cited by 7
Research progress on pathogenesis and clinical treatment of neuromyelitis optica spectrum disorders (NMOSDs)
Shen, X. (2023) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2023.107850 · Cited by 7
Distal Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination in a Patient with Solitary Plasmacytoma: A Case Report and Literature Review
Kubota, T., Shijo, T., Ikeda, K., Mitobe, Y., Umezawa, S., Misu, T., Hasegawa, T., & Aoki, M. (2023) · Internal Medicine · doi:10.2169/internalmedicine.1365-22 · Cited by 7
Isolated myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in adults: The importance of age of onset and prognosis-related radiological features
Zhao, J., Chen, X., Zhang, J., Liu, L., Wang, J., & Zhu, L. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105518 · Cited by 7
Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report
Gil‐Perotín, S., Castillo-Villalba, J., Polo, J. C., Gimeno, A. N., Mallada-Frechín, J., Miralles, F. C. P., Gascón, F., Alcalà-Vicente, C., Cubas-Núñez, L., & Casanova-Estruch, B. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00340 · Cited by 7
Reduced quality of life in a pediatric-onset Neuromyelitis optica spectrum disorders cohort
Paolilo, R. B., da Paz, J. A., Apóstolos‐Pereira, S. L., Rimkus, C. D. M., Callegaro, D., & Sato, D. K. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103252 · Cited by 7
Double hit – A case in point for dual seropositivity to AQP4 and MOG antibodies
Jain, K., Anita, M., & Netravathi, M. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578198 · Cited by 6
Translational insights from EAE models : decoding MOGAD pathogenesis and therapeutic innovation
Zhang, Y., & Li, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1530977 · Cited by 6
B cell depletion as a therapeutic strategy for neuromyelitis optica spectrum disorder: rationale, evidence, and challenges
Ochi, H., Nakamura, S., & Nakahara, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1635989 · Cited by 7
Immune signatures link myelin oligodendrocyte glycoprotein antibody–associated disease to other autoantibody-mediated conditions
Schmid, J., Alberti, C., Power, L., Núñez, N. G., Feo, D. D., Tyystjärvi, S., Kulsvehagen, L., Kreiner, V., Gomes, A. B. A. G. R., Lipps, P., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adw0358 · Cited by 6
A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
Zhou, L., Tan, X., Wang, L., Zhao, X., Qiu, W., & Yang, H. (2022) · Journal of Ophthalmology · doi:10.1155/2022/4951491 · Cited by 6
Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)
Hiya, S., Yoshimura, H., & Kawamoto, M. (2023) · eNeurologicalSci · doi:10.1016/j.ensci.2023.100461 · Cited by 6
Myelin Oligodendrocyte Glycoprotein (MOG) Associated Diseases: Updates in Pediatric Practice
Khoshnood, M. M., & Santoro, J. D. (2023) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2023.101056 · Cited by 6
Clinical and radiological features, treatment responses and prognosis in pediatric patients with co-existing anti-N-methyl-D-aspartate receptor and myelin oligodendrocyte glycoprotein antibody-associated encephalitis: A single center study
Liao, D., Zhong, L., Yang, L., He, F., Deng, X., Yin, F., & Peng, J. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105133 · Cited by 6
MOG-IgG is rare in AQP4-IgG seronegative NMO phenotype in Brazil
Pedrosa, D. A., Fernandes, G. B. P., Talim, N. C., Rosseto-Welter, E. A., Marques, A. G., Christo, P. P., Ponsá, T., Araújo, C. R., Queiroz, A. C. C., Rocha, A. C. H., et al. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106222 · Cited by 6
Epidemiology of neuromyelitis optica spectrum disorder
Sherman, M. A., & Boyko, A. N. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20211210725 · Cited by 6
Prodromal emesis in MOG-antibody associated disorder
Netravathi, M., Holla, V. V., Saini, J. S., & Mahadevan, A. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103463 · Cited by 6
Comparison of Clinical and Radiological Features of Aquaporin4 (AQP-4) Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) and Anti Myelin Oligodendrocyte Glycoprotein (Anti-MOG) Syndrome-Our Experience from Northwest India
Jain, R. S., Jain, D., Murarka, S., Vyas, A., Sharma, B., Srivastava, T., Kumar, K., Jain, Y., Rao, K., Agrawal, J., et al. (2022) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_860_21 · Cited by 6
Internuclear Ophthalmoplegia Characterizes Multiple Sclerosis Rather Than Neuromyelitis Optica Spectrum Disease
Hamza, M. M., Alas, B. F., Huang, C., Quon, J. C., Amezcua, L., Robers, M., & Gokoffski, K. K. (2022) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001534 · Cited by 7
Tumefactive demyelinating disorders as stroke mimics: Description of cases and systematic review of the literature
Vaišvilas, M., Vilionskis, A., Sasnauskaitė, I., Petrosian, D., Mickevičiūtė, E., & Giedraitienė, N. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104792 · Cited by 6
The Changing Landscape of Childhood Inflammatory Central Nervous System Disorders
Longoni, G., Levy, D. M., & Yeh, E. A. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.08.054 · Cited by 6
Magnetic resonance imaging in immune-mediated myelopathies
Wendebourg, M. J., Nagy, S., Derfuss, T. J., Parmar, K., & Schlaeger, R. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09206-2 · Cited by 7
Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
Liu, C., Zhu, M., & Wang, Y. (2019) · Journal of Visualized Experiments · doi:10.3791/59014 · Cited by 6
Clinical characteristics, disease course, and outcomes of paediatric patients with myelin oligodendrocyte glycoprotein-Ab associated disease: A retrospective clinical study
Zhang, M., Du, X., Zhou, S., Pan, G., Shen, J., Li, W., Yu, L., Zhou, Y., Zhang, Y., Wang, Y., et al. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.09.035 · Cited by 6
FLAMES with Elevated Myelin Basic Protein Followed by Myelitis
Hokama, H., Sakamoto, Y., Hayashi, T., Hatake, S., Takahashi, M., Kodera, H., Kutsuna, A., Nito, C., Nakane, S., Nagayama, H., et al. (2022) · Internal Medicine · doi:10.2169/internalmedicine.9439-22 · Cited by 6
Neuromyelitis Optica Spectrum Disorders in North Indian Population: Experience from a Tertiary Care Center
Sachdeva, J., Goyal, M., Singh, R., Kapila, A. T., Singh, P., Saikia, B., & Lal, V. (2022) · Neurology India · doi:10.4103/0028-3886.355118 · Cited by 6
Clinical features in very early-onset demyelinating disease with anti-MOG antibody
Nishiyama, M., Nagase, H., Matsumoto, M., Tomioka, K., Awano, H., Tanaka, T. J., Toyoshima, D., Fujita, K., Maruyama, A., Oyazato, Y., et al. (2017) · Brain and Development · doi:10.1016/j.braindev.2017.05.004 · Cited by 6
Chloride imbalance is involved in the pathogenesis of optic neuritis in neuromyelitis optica
Akaishi, T., Takahashi, T., Himori, N., Takeshita, T., Nakazawa, T., Aoki, M., & Nakashima, I. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.010 · Cited by 6
The role of the laboratory in the expanding field of neuroimmunology: Autoantibodies to neural targets
Naides, S. J. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.04.003 · Cited by 6
Simultaneous bilateral optic neuritis in China: clinical, serological and prognostic characteristics
Kang, H., Liu, Z., Li, H., Chen, T., Ai, N., Xu, Q., Cao, S., Tao, Y. K., & Wei, S. (2019) · Acta Ophthalmologica · doi:10.1111/aos.14013 · Cited by 6
First Clinical Experience with Anti-myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis
Heckmann, J., Todorova, M. G., Müller, S., Broser, P. J., & Sturm, V. (2020) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-1068-2506 · Cited by 6
Excessive MALAT1 promotes the immunologic process of neuromyelitis optica spectrum disorder by upregulating BAFF expression
Chen, J., Zhang, L., Lin, J., Wang, Z., & Lin, A. (2023) · Translational Neuroscience · doi:10.1515/tnsci-2022-0306 · Cited by 5
Therapeutic plasma exchange for neuromyelitis optica attacks: Evidence and challenges from a real-world cohort from Brazil
de Almeida, G. M. R., de Araujo, R. S., Castrillo, B. B., Silva, G. D., Fortini, I., Gonçalves, M. R. R., Castro, L. H. M., Tatsui, N. H., Adoni, T., Sato, D. K., et al. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578295 · Cited by 5
The diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children
Yılmaz, Ü. (2024) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2024.00069 · Cited by 5
Longitudinally extensive transverse myelitis: Impact on functional prognosis and mortality in a 10-year follow-up cohort
Silva, P. B. R., Apóstolos‐Pereira, S. L., Aguiar, G., Terrim, S., Filho, F. V. M., Silva, G. D., Neto, H. R. S., Boaventura, M., Adoni, T., Sato, D. K., et al. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106279 · Cited by 6
Distinguishing Neuromyelitis Optica Spectrum Disorders Subtypes: A Study on AQP4 and C3d Epitope Expression in Cytokine‐Primed Human Astrocytes
Alisch, M., Foersterling, F., Zocholl, D., Muinjonov, B., Schindler, P., Duchnow, A., Otto, C., Ruprecht, K., Schmitz‐Hübsch, T., Jarius, S., et al. (2025) · Glia · doi:10.1002/glia.24675 · Cited by 5
Comparison of clinico-radiological profile, optical coherence tomography parameters, and outcome in MOGAD and Neuromyelitis optica spectrum disorder subtypes: A prospective observational study
Dhar, N., Kumar, M., Tiwari, A., Samanta, R., Bhadoria, A. S., Vivekanandhan, S., Saxena, S., & Kumar, N. (2023) · Journal of Neurosciences in Rural Practice · doi:10.25259/jnrp_8_2022 · Cited by 5
Phenotype of Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in Children
Han, J. Y., Kim, S. Y., Kim, W. J., Kim, H., Cho, A., Choi, J., Chae, J., Kim, K. J., Kwon, Y. S., Yoo, I. H., et al. (2024) · Journal of Clinical Neurology · doi:10.3988/jcn.2024.0276 · Cited by 5
Comparison of clinical features of aquaporin-4 positive neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein associated disorder (MOGAD), and double seronegative NMOSD - A single center experience
Çakan, M., Demirel, E., Çimen, B., Acar, N. P., Çolpak, A. İ., Karabudak, R., & Tuncer, A. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578591 · Cited by 5
Optic Neuritis
Eggenberger, E. (2025) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001560 · Cited by 5
Disease-modifying therapies should be stopped in NMOSD patients in remission – No
Rotstein, D. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519832249 · Cited by 5
Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody
Takano, S., Hanabusa, A., Yoshikawa, Y., Sassa, K., Shimura, A., Shoji, T., Ohde, H., Shinoda, K., & Yamanouchi, H. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01339 · Cited by 5
Imaging of Neuromyelitis Optica Spectrum Disorders
Hung, S. (2020) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2020.02.006 · Cited by 5
Markedly Elevated Serum Level of T-Helper Cell 17-Related Cytokines/Chemokines in Acute Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis
Kang, H., Li, H., Ai, N., Liu, H., Xu, Q., Tao, Y. K., & Wei, S. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.589288 · Cited by 5
Practical recognition tools of immunoglobulin G serum antibodies against the myelin oligodendrocyte glycoprotein‐positive optic neuritis and its clinical implications
Lotan, I., Oertel, F. C., Chien, C., Asseyer, S., Paul, F., & Stiebel‐Kalish, H. (2020) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12623 · Cited by 5
Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment
Takahashi, K., Takeuchi, H., Fukai, R., Nakamura, H., Morihara, K., Higashiyama, Y., Takahashi, T., Doi, H., & Tanaka, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.625465 · Cited by 5
Neuromyelitis optica spectrum and myelin oligodendrocyte glycoprotein antibody‐related disseminated encephalomyelitis
Misu, T., & Fujihara, K. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12491 · Cited by 5
Isolated recurrent myelitis in a persistent MOG positive patient
Anis, S., Regev, K., Pittock, S. J., Flanagan, E. P., Alcalay, Y., & Gadoth, A. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.02.016 · Cited by 5
Aquaporin-4 neuromyelitis optica spectrum disorder in a 2-year-old girl: Diagnostic and treatment considerations
Khan, T. R., & Wang, C. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102030 · Cited by 5
Comparative study of AQP4 antibody-related diseases and MOG antibody-related diseases among the population in Hunan, China
Chen, X., Ren, Y., Zhang, Y., & Lu, W. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01455-7 · Cited by 5
Understanding Multiple Sclerosis Better in 2014 – Environmental Factors, Remyelination, Diagnostic Techniques, Treatment Decisions and the Future Focus of Multiple Sclerosis Treatment
Efendi, H., Karabudak, R., Kantarci, O. H., & Sıva, A. (2015) · European Neurological Review · doi:10.17925/enr.2015.10.02.148 · Cited by 5
Immunotherapies for neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease
Lotan, I., Anderson, M., & Levy, M. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90887-0.00015-8 · Cited by 4
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder
Mahler, J. V., Vallejos, G. B., Mikami, T., Bilodeau, P., Anderson, M., Drosu, N. C., Bobrowski‐Khoury, N., Silva, G. D., Solti, M., Apóstolos‐Pereira, S. L., et al. (2026) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200514 · Cited by 6
Clinical characteristics of anti-myelin oligodendrocyte glycoprotein antibody among aquaporin-4 negative neuromyelitis optica spectrum disorders in Egyptian patients
Taha, S., Bakr, S. I., Fouad, N. T. A., Zamzam, D., & Mohamed, Y. A. (2025) · Scientific Reports · doi:10.1038/s41598-024-83760-2 · Cited by 4
Neuromyelitis optica spectrum disorders and anti-myelin oligodendrocyte glycoprotein positive optic neuropathies
Murtagh, P. J., Stephenson, K. A. J., Gaughan, M., Ryan, D. T., McNeill, G., McGuigan, C., & Cassidy, L. (2022) · International Journal of Ophthalmology · doi:10.18240/ijo.2022.07.09 · Cited by 4
Relapsing antibody-negative patients with features of neuromyelitis optica spectrum disorders: Differences in N -acetylaspartate level in the cervical spinal cord indicate distinct underlying processes
Kossowski, B., Kong, Y., Klimiec, E., Emir, U. E., Palace, J. A., & Juryńczyk, M. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585221115304 · Cited by 4

Authors: Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., Lino, A. M. M., Misu, T., Leite, M. I., Aoki, M., & Fujihara, K.
Affiliations: Universidade Federal de Minas Gerais (BR)
From the Departments of Neurology (D.K.S., T.T., I.N., M.A.) and Multiple Sclerosis Therapeutics (T.M., K.F.), Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology (D.C., F.M.d.H.J., S.L.A.-P., R.F.S., A.M.M.L.), Faculty of Medicine, University of São Paulo, Brazil; CIEM MS Research Center (M.A.L.-P., N.T.), Federal University of Minas Gerais Medical School, Belo Horizonte, Brazil; Neuroimmunology Group (P.J.W., M.I.L.), Nuffield Department of Clinical Neurosciences,...
ORCID: Sato, Douglas Kazutoshi
Callegaro, Dagoberto
Waters, Patrick J.
Takahashi, Toshiyuki
Nakashima, Ichiro
Lino, Angelina Maria Martins
Misu, Tatsuro
Leite, Maria Isabel
Aoki, Masashi
Fujihara, Kazuo
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2014-02-11
Volume: 82
Issue: 6
Pages: 474-481
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0000000000000101
PMC: PMC3937859
OpenAlex: W2103812851
Cited by: 850
References: 21
Citations by year: 2026: 25 · 2025: 41 · 2024: 45 · 2023: 67 · 2022: 69 · 2021: 94 · 2020: 95 · 2019: 83 · 2018: 76 · 2017: 82 · 2016: 66 · 2015: 66 · 2014: 38
FWCI: 62.41
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
Locations: Neurology (publishedVersion, cc-by-nc-nd)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Japan Society for the Promotion of Science (22229008)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords: neuromyelitis optica spectrum disorder, anti-MOG antibodies, aquaporin-4 antibodies, seronegative NMOSD, clinical features, optic neuritis, spinal cord lesions, disease phenotypes, functional recovery, relapse rate
MeSH terms: Adolescent, Adult, Aged, Autoantibodies, Child, Preschool, Female, Humans, Male, Middle Aged, Neuromyelitis Optica, Phenotype, Sex Factors, Aquaporin 4, Young Adult, Myelin-Oligodendrocyte Glycoprotein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks